medline.ch Urologie-Nephrologie Tumoren BPH

	Genomic Landscape of Metastatic Urothelial Cancer in a Multicenter Cohort From Argentina. JCO Glob Oncol Cayol F, Macharashvili I, Barochiner J, Dominguez MP, Menna E, Perez Mesa PJ, Pandolfi J, Carranza O, Sanchez R, Marchioni A, Gueron G, Pena L, Cerini M, Cutuli H, Rivello HG, Taetti G, Camacho AF. PMID: 42659586 [PubMed - indexed for MEDLINE]
	Disparities in disease profiles among Afro-Brazilians and public healthcare patients with prostate cancer: real-world data from Brazil. Einstein (Sao Paulo) Nagy ALS, Vazquez YG, Sousa YG, Centrone NY, Rocioli Junior UD, Tustumi F, Moura F, Maluf F, Usón Junior PLS. PMID: 42659448 [PubMed - indexed for MEDLINE]
	Advancing Homologous Recombination Repair Mutation Testing in Prostate Cancer in Australia: Shifting the Focus to Hormone Sensitive Prostate Cancer. Asia Pac J Clin Oncol Azad AA, Murphy DG, Kwan EM, Joshua AM. PMID: 42658786 [PubMed - as supplied by publisher]
	Navigating PI-RADS 3 Lesions: Reducing Uncertainty and Guiding Prostate Cancer Diagnostic Decision Making. Radiographics Nicola R, Correia ETO, Antunes PM, Lopes Pereira de Borborema C, Schoots IG, Bittencourt LK. PMID: 42658725 [PubMed - indexed for MEDLINE]
	Feasibility of Real-Time Central Risk Assignment for Children's Oncology Group Pediatric Renal Tumor Trials. Pediatr Blood Cancer Mullen EA, Renfro LA, Ehrlich PF, Khanna G, Treece AL, Gratias EJ, Cost NG, Grundy PE, Fernandez CV, Dome JS, Geller JI, AREN03B2 Study Committee. PMID: 42657661 [PubMed - as supplied by publisher]
	Physician- and Patient-Reported Outcomes Following Contemporary Image Guided Intensity Modulated Proton Therapy for Prostate Cancer: Results From the Prospective PRO-Cube Study. Adv Radiat Oncol Sundar S, Chilukuri S, Arjunan M, Kamath R, Sinha A, Palani M, Panda PK, Mullapally SK, Ramani S, Ragavan N, Jawahar P, Amalachandran J, Sharma DS, Jalali R. PMID: 42657230 [PubMed]
	Association between serum preptin levels and bone metastasis in newly diagnosed prostate cancer: a prospective exploratory study. J Bone Oncol Gülba, Akda, Gül D, Halis H, Engin EO, Çimen H, Hac. PMID: 42656999 [PubMed]
	Serum multi-element profiling and a Metallobalance index for noninvasive differentiation of canine prostatic adenocarcinoma: a pilot case-control study. Front Vet Sci Yamada N, Ishigaki K, Hayakawa T, Iida K, Yamaoka S, Wang P, Asano K. PMID: 42656407 [PubMed]
	Study protocol on quality of life and erectile function recovery in unfavorable intermediate-risk prostate cancer: REDI-CaP trial. Future Oncol Di Franco R, Mercogliano S, Mottareale R, Borzillo V, Scipilliti E, Serra M, Buonanno F, Ametrano G, Perrone F, Piccirillo MC, Pignata S, Rossetti S, Perdonà S, Franzese D, Izzo A, Muscariello R, Grimaldi G, Castaldo L, Lastoria S, Di Gennaro F, Raddi M, Petrillo A, Simonetti I, Cavalcanti E, De Falco R, di Franco MA, Maiolino P, Pagliuca MI, Roberta D, Vincenzo R. PMID: 42656189 [PubMed - as supplied by publisher]
	Extended Versus Non-Extended Lymphadenectomy in Radical Cystectomy for Bladder Cancer: A Systematic Review and Meta-Analysis. J Surg Oncol Azevedo MFD, Brito PHS, Kallas-Silva L, Liebl B, Constantinou BT, Benedicto BC, Oliveira LP, Cordeiro MD, Nahas WC, Shabana W, Shahrour W, Ribeiro-Filho LA, Suartz CV. PMID: 42655992 [PubMed - as supplied by publisher]
	Integrating Molecular Classification Based on FGFR3, KRAS, HRAS, and TP53 Mutation With TNM Staging Modestly Improves Prediction of Prognosis of Upper Tract Urothelial Carcinoma After Surgery. Int J Urol Yanagida K, Takada I, Ishida T, Takei K, Kishitani K, Minagawa H, Kawai T, Kaneko T, Sasajima Y, Nakagawa T. PMID: 42655970 [PubMed - indexed for MEDLINE]
	The Four-Bladder Neck Implant Technique on Early Outcomes After Prostatic Urethral Lift: A Japanese Prospective Single-Center Study. Int J Urol Anan G, Fujishima Y, Minami H, Ishii T, Kaga K. PMID: 42655944 [PubMed - indexed for MEDLINE]
	Prognostic Value of the Lung Immune Prognostic Index in Metastatic Renal Cell Carcinoma Treated With Second-Line Immunotherapy. Int J Urol Özberk U, Perkin P, Ye, Alg, Karaka, Ak, Uçar G. PMID: 42655932 [PubMed - indexed for MEDLINE]
	Outcomes and Predictive Factors for Gynecologic Organ Involvement in Radical Cystectomy for Female Bladder Cancer Patients: A Multicenter Retrospective Cohort Study. Medicina (Kaunas) Arikan MG, Arda E, , Yilmaz H, Suer E, Akgul M, Yazici S, Bolat D, Aslan G, Akan S, Turkeri L. PMID: 42654506 [PubMed - indexed for MEDLINE]
	Integrated Inflammatory and Nutritional Biomarkers in Metastatic Renal Cell Carcinoma Treated with Second- or Later-Line Nivolumab: A Retrospective Cohort Study. Medicina (Kaunas) U, Kerimo, Koçak MZ, Aykut T, Ça, Karakurt Ery, Araz M, Artaç M. PMID: 42654418 [PubMed - indexed for MEDLINE]
	Clinicopathological Analysis of Prostate Cancer in Young Men: Experience of a Tertiary Referral Hospital in Western Romania. Medicina (Kaunas) Dema V, Croitor A, Barna RA, Dema S, T, Nanu M, Mîrnea D, C, Bardan R, Cump. PMID: 42654362 [PubMed - indexed for MEDLINE]
	Gold Nanoparticles in Prostate Cancer: Advances in Targeted Therapy, Diagnostics, and Precision Nanomedicine. Pharmaceuticals (Basel) Hani U, Hamod MA, Hamood NA, Alhamhoom Y, Ghazwani M, AlQahtani F, Helal HA, Osmani RAM. PMID: 42653769 [PubMed]
	Human Group IIA Secreted Phospholipase A(2) and the Prostate Cancer Tumor Microenvironment: Potential Mechanisms. Int J Mol Sci Andarva M, Elias MG, Sajinovic M, Roberts TL, de Souza P, Scott KF. PMID: 42653281 [PubMed - indexed for MEDLINE]
	Molecular Mechanisms and Immune Regulation in Prostate Cancer: A Review. Int J Mol Sci Murray NP. PMID: 42653263 [PubMed - indexed for MEDLINE]
	Integrated Mendelian Randomization and Single-Cell Transcriptomics Reveal T Cell Immune Mechanisms in Systemic Lupus Erythematosus-Bladder Cancer Comorbidity. Life (Basel) Zhang D, Ren H, Bai Y, Han P. PMID: 42653069 [PubMed]

Artikel 1 - 20 / 190825

Seite 1 von 9542



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung